Lv1
40 积分 2023-08-31 加入
The superiority of MabSelect VL, Cytiva's second-generation Protein L resin, over three other affinity resins in purifying a VHH-containing trispecific antibody
1个月前
已完结
Generation and characterization of a potent fully human monoclonal antibody against the interleukin-23 receptor
2个月前
已完结
Preclinical evaluation of a TL1A × IL-23 bispecific antibody for immune-mediated inflammatory diseases
2个月前
已完结
P130 ORKA-001: a novel extended half-life monoclonal antibody targeting IL-23 with the potential to improve upon currently available therapies for psoriasis
2个月前
已关闭
Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment
3个月前
已完结
The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy
3个月前
已完结
DOP033 Pre-Clinical Development of SL-325, a High Affinity DR3 Blocking Antibody, for Durable Blockade of the DR3/TL1A Axis in Inflammatory Bowel Disease
4个月前
已完结
Abstract 5482: In vitro assays for prediction of ADC hematological toxicities: contribution of antibody, linker, and payload
9个月前
已关闭
TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease
1年前
已完结
TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells
1年前
已完结
皖公网安备34019202002308
